Akumin (AKU) Stock Forecast, Price Target & Predictions
AKU Stock Forecast
Akumin stock forecast is as follows: an average price target of $3.00 (represents a 934.48% upside from AKU’s last price of $0.29) and
AKU Price Target
Akumin Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Nov 14, 2022 | - | Canaccord Genuity | $3.00 | $1.47 | 104.08% | 934.48% |
Akumin Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $0.29 | $0.29 | $0.29 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Akumin Financial Forecast
Akumin Revenue Forecast
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Sep 20 | Jun 20 | Sep 19 | Jun 19 | Sep 18 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | $184.84M | $187.59M | $184.63M | $186.60M | $67.12M | $53.63M | $68.87M | $53.99M | $39.13M | $36.77M |
Avg Forecast | $415.89M | $369.68M | $323.47M | $187.50M | $185.70M | $184.84M | $249.09M | $1.02B | $1.01B | $75.76M | $83.66M | $68.87M | $87.46M | $67.64M | $52.96M |
High Forecast | $415.89M | $369.68M | $323.47M | $187.50M | $185.70M | $184.84M | $247.10M | $1.02B | $1.01B | $90.91M | $83.66M | $68.87M | $87.46M | $67.64M | $52.96M |
Low Forecast | $415.89M | $369.68M | $323.47M | $187.50M | $185.70M | $184.84M | $247.10M | $1.02B | $1.01B | $60.61M | $83.66M | $68.87M | $87.46M | $67.64M | $52.96M |
# Analysts | - | - | - | 1 | 1 | - | 1 | 1 | - | 19 | 9 | 8 | 12 | 9 | 9 |
Surprise % | - | - | - | - | - | 1.00% | 0.75% | 0.18% | 0.18% | 0.89% | 0.64% | 1.00% | 0.62% | 0.58% | 0.69% |
Akumin EBITDA Forecast
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Sep 20 | Jun 20 | Sep 19 | Jun 19 | Sep 18 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | 1 | 1 | - | 1 | 1 | - | 19 | 9 | 8 | 12 | 9 | 9 |
EBITDA | - | - | - | - | - | $91.67M | $30.44M | $35.74M | $36.20M | $21.22M | $17.38M | $22.05M | $15.55M | $7.47M | $6.75M |
Avg Forecast | $82.14M | $73.01M | $63.88M | $37.03M | $36.67M | $36.51M | $49.19M | $202.15M | $199.53M | $21.26M | $-8.21M | $19.32M | $18.21M | $7.39M | $7.47M |
High Forecast | $82.14M | $73.01M | $63.88M | $37.03M | $36.67M | $36.51M | $48.80M | $202.15M | $199.53M | $25.51M | $-6.57M | $23.19M | $21.86M | $8.87M | $8.96M |
Low Forecast | $82.14M | $73.01M | $63.88M | $37.03M | $36.67M | $36.51M | $48.80M | $202.15M | $199.53M | $17.01M | $-9.85M | $15.46M | $14.57M | $5.92M | $5.97M |
Surprise % | - | - | - | - | - | 2.51% | 0.62% | 0.18% | 0.18% | 1.00% | -2.12% | 1.14% | 0.85% | 1.01% | 0.90% |
Akumin Net Income Forecast
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Sep 20 | Jun 20 | Sep 19 | Jun 19 | Sep 18 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | 1 | 1 | - | 1 | 1 | - | 19 | 9 | 8 | 12 | 9 | 9 |
Net Income | - | - | - | - | - | $-96.65M | $-29.19M | $-49.33M | $-49.74M | $-1.57M | $-2.55M | $1.99M | $-418.04K | $706.38K | $2.13M |
Avg Forecast | $139.50M | $121.51M | $142.68M | $189.01M | $-21.45M | $107.91M | $129.32M | $176.84M | $115.09M | $2.19M | $-4.74M | $1.99M | $-1.56M | $337.07K | $2.07M |
High Forecast | $139.50M | $121.51M | $142.68M | $189.01M | $-21.45M | $107.91M | $129.32M | $176.84M | $115.09M | $2.62M | $-3.79M | $2.39M | $-1.25M | $404.49K | $2.48M |
Low Forecast | $139.50M | $121.51M | $142.68M | $189.01M | $-21.45M | $107.91M | $129.32M | $176.84M | $115.09M | $1.75M | $-5.69M | $1.59M | $-1.87M | $269.66K | $1.65M |
Surprise % | - | - | - | - | - | -0.90% | -0.23% | -0.28% | -0.43% | -0.72% | 0.54% | 1.00% | 0.27% | 2.10% | 1.03% |
Akumin SG&A Forecast
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Sep 20 | Jun 20 | Sep 19 | Jun 19 | Sep 18 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | 1 | 1 | - | 1 | 1 | - | 19 | 9 | 8 | 12 | 9 | 9 |
SG&A | - | - | - | - | - | - | $399.00K | $867.00K | $556.00K | $568.38K | $565.50K | $852.59K | $935.34K | $1.42M | $2.13M |
Avg Forecast | $6.30M | $5.60M | $4.90M | $2.84M | $2.81M | $2.80M | $3.77M | $15.50M | $15.30M | $937.85K | $882.18K | $852.59K | $1.52M | $4.85M | $5.12M |
High Forecast | $6.30M | $5.60M | $4.90M | $2.84M | $2.81M | $2.80M | $3.74M | $15.50M | $15.30M | $1.13M | $1.06M | $1.02M | $1.82M | $5.82M | $6.14M |
Low Forecast | $6.30M | $5.60M | $4.90M | $2.84M | $2.81M | $2.80M | $3.74M | $15.50M | $15.30M | $750.28K | $705.75K | $682.07K | $1.21M | $3.88M | $4.09M |
Surprise % | - | - | - | - | - | - | 0.11% | 0.06% | 0.04% | 0.61% | 0.64% | 1.00% | 0.62% | 0.29% | 0.42% |
Akumin EPS Forecast
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Sep 20 | Jun 20 | Sep 19 | Jun 19 | Sep 18 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | 1 | 1 | - | 1 | 1 | - | 19 | 9 | 8 | 12 | 9 | 9 |
EPS | - | - | - | - | - | $-1.07 | $-0.32 | $-0.70 | $-0.56 | $-0.10 | $-0.11 | $0.03 | $-0.01 | - | $0.02 |
Avg Forecast | $1.54 | $1.34 | $1.58 | $2.09 | $-0.24 | $1.19 | $1.43 | $1.95 | $1.27 | $0.03 | $0.15 | $0.03 | $0.05 | - | $0.05 |
High Forecast | $1.54 | $1.34 | $1.58 | $2.09 | $-0.24 | $1.19 | $1.43 | $1.95 | $1.27 | $0.04 | $0.15 | $0.03 | $0.05 | - | $0.05 |
Low Forecast | $1.54 | $1.34 | $1.58 | $2.09 | $-0.24 | $1.19 | $1.43 | $1.95 | $1.27 | $0.02 | $0.15 | $0.03 | $0.05 | - | $0.05 |
Surprise % | - | - | - | - | - | -0.90% | -0.22% | -0.36% | -0.44% | -3.33% | -0.73% | 1.00% | -0.20% | 2.06% | 0.40% |
Akumin Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
DRIO | DarioHealth | $0.95 | $10.75 | 1031.58% | Buy |
STIM | Neuronetics | $0.73 | $8.00 | 995.89% | Buy |
AKU | Akumin | $0.29 | $3.00 | 934.48% | - |
GTH | Genetron | $4.03 | $10.00 | 148.14% | - |
QGEN | Qiagen | $46.36 | $52.37 | 12.96% | Buy |
SHC | Sotera Health Company | $16.80 | $16.93 | 0.77% | Buy |
OLK | Olink AB (publ) | $26.08 | $21.50 | -17.56% | Hold |
AKU Forecast FAQ
Will Akumin stock go up soon?
According to Wall Street analysts' prediction for AKU stock, the company can go up by 934.48% (from the last price of $0.29 to the average price target of $3), up by 934.48% based on the highest stock price target, and up by 934.48% based on the lowest stock price target.
Can Akumin stock reach $0?
AKU's average twelve months analyst stock price target of $3 supports the claim that Akumin can reach $0 in the near future.
What are Akumin's analysts' financial forecasts?
AKU's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $807.12M (high $805.14M, low $805.14M), average EBITDA is $159.4M (high $159.01M, low $159.01M), average net income is $404.79M (high $404.79M, low $404.79M), average SG&A $12.22M (high $12.19M, low $12.19M), and average EPS is $4.47 (high $4.47, low $4.47).
Did the AKU's actual financial results beat the analysts' financial forecasts?
Based on Akumin's last annual report (Dec 2022), the company's revenue was $749.63M, which missed the average analysts forecast of $2.03B by -63.14%. Apple's EBITDA was $139.86M, missing the average prediction of $401.68M by -65.18%. The company's net income was $-152M, missing the average estimation of $291.93M by -151.93%. Apple's SG&A was $3.24M, missing the average forecast of $30.8M by -89.47%. Lastly, the company's EPS was $-1.69, missing the average prediction of $3.23 by -152.39%. In terms of the last quarterly report (Jun 2023), Akumin's revenue was $184.84M, beating the average analysts' forecast of $184.84M by 0%. The company's EBITDA was $91.67M, beating the average prediction of $36.51M by 151.12%. Akumin's net income was $-96.652M, missing the average estimation of $107.91M by -189.57%. The company's SG&A was $0, missing the average forecast of $2.8M by -100.00%. Lastly, the company's EPS was $-1.07, missing the average prediction of $1.19 by -189.74%